Abstract
Background
The radiofrequency (RF) maze procedure can effectively restore sinus rhythm in most patients with persistent atrial fibrillation (AF) and mitral disease. However, long-term results and predictors for late AF recurrence are still under investigation.
Methods
From December 1995 to November 2011, 207 consecutive patients with persistent AF and mitral disease underwent RF maze procedure and concomitant mitral surgery. The mean age was 54±12.4 year-old. Mitral surgery was performed in all patients and concomitant procedures including tricuspid surgery, aortic valve surgery, and atrial septal defect closure were carried on 164 patients.
Results
The in-hospital mortality was 3.9% (n=8) and late mortality was 8.2% (n=17). After a mean follow-up period of 101±50.9 months, 154 patients (74.4%) had long-term sinus conversion. A permanent pacer was implanted in 8 patients (3.9%). By Cox multivariate survival regression analysis, predictors for long-term sinus conversion were identified to be the duration of persistent AF, preoperative left atrial (LA) diameter, preoperative right atrial (RA) area, and preoperative beta-blocker use. The receiver operating characteristic (ROC) curve analysis showed that the best cutoff value for persistent AF duration, preoperative LA diameter, and preoperative RA area were 59.5 months, 59.85 mm, and 25.65 cm2.
Conclusions
Longer persistent AF duration, larger preoperative LA diameter, larger preoperative RA area and preoperative beta-blocker use were the predictors for negative long-term outcome of RF maze procedure for the patients with persistent AF underwent concomitant mitral surgery. Timely referral of patients for surgery is mandatory.
Keywords: Atrial fibrillation (AF), maze procedure, mitral surgery, radiofrequency (RF)
Introduction
Atrial fibrillation (AF) is the most frequent cardiac arrhythmia and present in 0.4% of the general population (1). The risk of systemic embolization, cardiac morbidities and mortality are increased in the patients with AF (2,3). In patients undergoing off-pump coronary artery bypass grafting, postoperative AF could even cause delayed stroke (4). Anticoagulation therapy has been recommended for prevention of systemic embolization. However, the attitude for anticoagulation therapy for the patients with AF at peri-stroke period is rather conservative due to the concern regarding the late hemorrhagic complication (5). In the patients underwent mitral surgery, concomitant AF is present in as high as 50% of patients (6). Cox et al. developed Cox Maze procedure and successfully treated the patients with drug-refractory AF (7,8). Since the original maze procedure required extensive cut-and-saw in both atria, modified maze procedure using variable energy sources to achieve the ablative purpose were developed (9-14). However, the long-term results and predictors for late AF recurrence are still under investigation. This study investigated the long-term results and the predictive values for late AF recurrence in 207 consecutive patients after mitral surgery and radiofrequency (RF) maze procedure for persistent AF.
Methods
Patient selection
A single-center retrospective clinical database analysis of 207 consecutive patients who underwent the RF maze procedure for persistent AF concomitant to the mitral surgery from December 1995 to November 2011 was conducted. Associated procedures including tricuspid surgery, aortic valve surgery, and atrial septal defect closure were carried on 164 patients (Table 1). There were 106 female. The mean age was 54±12.4 (ranged from 21 to 81) years old. This study was approved by the Institutional Review Board of Chang Gung Medical Foundation (IRB number 201600911B0), and the need for written informed consent from the patients was waived.
Table 1. Demographic data of the 199 patients.
Variables | Success (n=154) | Failure (n=45) | P value |
---|---|---|---|
Age (year) | 52.7±12.3 | 55.4±12.5 | 0.865 |
Gender (male), n (%) | 74 (48.1) | 21 (46.7) | 0.500 |
Persistent AF duration (month) | 30.5±41.3 | 98.2±64.9 | <0.001 |
Hypertension, n (%) | 23 (14.9) | 9 (20.0) | 0.480 |
Diabetes mellitus, n (%) | 13 (8.4) | 5 (11.1) | 0.770 |
Hyperlipidemia, n (%) | 11 (7.1) | 2 (4.4) | 0.740 |
CAD, n (%) | 7 (4.5) | 0 (0) | 0.200 |
CVA, n (%) | 9 (5.8) | 1 (2.2) | 0.460 |
Hyperthyroidism, n (%) | 5 (3.2) | 2 (4.4) | 0.660 |
Digitalis, n (%) | 126 (81.8) | 38 (84.4) | 0.830 |
Beta-blocker, n (%) | 34 (22.1) | 13 (28.9) | 0.500 |
Calcium blocker, n (%) | 22 (14.3) | 8 (17.8) | 0.640 |
ACEI, n (%) | 90 (58.4) | 22 (48.9) | 0.450 |
Preoperative NYHA Fc class, n (%) | 0.015 | ||
I | 1 (0.6) | 0 (0) | |
II | 35 (22.7) | 1 (2.2) | |
III | 96 (62.3) | 39 (86.7) | |
IV | 22 (14.3) | 5 (11.1) | |
Preoperative LA size (mm) | 52.2±8.8 | 61.1±10.5 | 0.030 |
Preoperative LA area (cm2) | 43.2±15.6 | 61.1±25.7 | <0.001 |
Preoperative RA area (cm2) | 24.3±8.5 | 30.5±9.5 | 0.230 |
Preoperative LVEDD (mm) | 55.4±10.0 | 53.4±7.4 | 0.032 |
Preoperative LVESD (mm) | 36.0±9.4 | 35.0±6.2 | 0.013 |
LV EF (%) | 62.6±13.3 | 62.2±9.1 | 0.008 |
MVD, n (%) | 0.480 | ||
MS | 19 (12.3) | 11 (24.4) | |
MR | 74 (48.1) | 16 (35.6) | |
MS + MR | 61 (39.6) | 18 (40.0) | |
AVD, n (%) | 33 (21.4) | 8 (17.8) | 0.680 |
TVD, n (%) | 100 (64.9) | 37 (82.2) | 0.029 |
ASD, n (%) | 11 (7.1) | 3 (6.7) | 1.000 |
ACEI, angiotensin converting enzyme inhibitor; AF, atrial fibrillation; ASD, atrial septal defect; AVD, aortic valve disease; CAD, coronary artery disease; CVA, cerebral vascular disease; EF, ejection fraction; Fc, functional; LA, left atrial; LV, left ventricle; LVEDD, left ventricular end diastolic diameter; LVESD, left ventricular end systolic diameter; RA, right atrial; MR, mitral regurgitation; MS, mitral stenosis; MVD, mitral valve disease; NYHA Fc class, New York Heart Association Functional Classification; TVD, tricuspid valve disease.
RF maze procedure
The RF maze procedure was initially conducted with a handmade saline-irrigated quadripolar steerable electrode catheter (Mansfield, Watertown, MA, USA) and a RF generator (EPT-1000; EP Technologies, Inc., Sunnyvale, CA, USA) guided by direct visualization during the period when the commercialized surgical ablation device was not available. Subsequently, since May 2005, the same procedure was carried with Cardioblate Monopolar RF ablator (Medtronic, Parkway, MN, USA). This technique was described elsewhere in detail and has been demonstrated to create transmural and continuous lesions (12-14).
Postoperative protocol
Both atrial and ventricular temporary pacing wires were employed in case of perioperative dysrhythmia. Cardiac rhythm was constantly monitored in the intensive care unit. In the general ward, a 12-lead electrocardiogram (ECG) was performed once each day and whenever subjective symptoms of dysrhythmias were noted. In contrast to other reports, any class I or III antiarrhythmics were not used in our practice in order to exclude chemical conversion. The patient was discharged after 2 weeks of heparinization. Persistent sinus restoration or spontaneous sinus conversion was considered as successful sinus conversion at discharge after 2 weeks of postoperative monitoring. Any atrial dysrhythmia was not converted either electrically or chemically during this period. Warfarin was administered in all patients and stopped 6 weeks later only in patients with successful sinus rhythm and atrial contraction restoration following reparative surgery or tissue valve replacement.
Cardiac rhythm and dimensions at follow-up
After hospital discharge, patients received monthly to trimonthly follow-up for medication adjustment, rhythm analysis, and chamber size evaluation with 12-lead ECG and two-dimensional echocardiogram. A 24-hour Holter ECG monitor was performed whenever symptoms or signs of dysrhythmia were noted or detected during the routine ECG and echocardiographic follow-up. M-mode measurements were performed following the recommendations of the American Society of Echocardiography for atrial dimensions (15). Atrial areas were measured by planimetry in a 4-chamber view. The maximum areas were the average of measurements over 5 beats. Early diastolic ventricular filling, filling by atrial contraction across the tricuspid and mitral valves, and total time-velocity integrals were recorded for analysis, as well.
Statistical analysis
Statistical analysis was performed using the Statistical Package for the Social Sciences for Windows software system, Version 22.0 (SPSS Inc., Chicago, IL, USA). Continuous variables acquired from the clinical characteristics were expressed as the mean ± standard deviation and were compared using the student t-test. The chi-squared test or Fisher’s exact test according to the number of events for variables appraised was used for comparisons made between categorical variables. Cox survival regression model was used to determine factors of AF recurrence after surgical ablation. Factors for which the univariable analysis gave a p value of less than 0.1 were included in the multivariable analysis. Hazard ratio (HR) and 95% confidence interval (CI) were calculated. Youden index (sensitivity + specificity − 1) of receiver operating characteristic (ROC) curve was calculated to find out the best cutoff values of persistent AF duration, preoperative left atrial (LA) diameter and preoperative right atrial (RA) area to predict late AF recurrence. Sensitivity, specificity and accuracy were investigated by the Fisher’s exact test. Survival curves for the incidence of AF recurrence by persistent AF duration, preoperative LA diameter, and preoperative RA area were calculated with the Kaplan-Meier method and a log-rank test was used to assess the statistical significance. A two-tailed probability value of less than 0.05 was considered statistically significant.
Results
Surgical outcomes
Among the 207 patients, there were 8 in-hospital deaths (3.9%). The remaining 199 patients including 109 rheumatic and 90 degenerative patients were divided into success sinus restoration (success, n=154) and failed sinus restoration (failure, n=45) groups according to the rhythm at discharge after 2 weeks of postoperative continuous monitoring (Table 1). The follow-up was 100% complete. During the mean follow-up period of 101±50.9 months, stroke was documented in 3 patients (1.4%), 8 patients (3.9%) developed sick sinus syndrome and received dual chamber permanent pacemaker implantation. There was no any sustained atrial arrhythmia documented over the whole course till the last follow-up of this study in 154 of 207 patients (74.4%). There were no complications associated with the RF maze procedure. The Failure group had longer persistent AF duration, worse preoperative New York Heart Association functional class, larger preoperative LA diameter, poorer left ventricular ejection fraction, larger preoperative left ventricular end systolic and end diastolic diameters. Late mortality occurred in 17 patients (8.2%). In these 17 patients, 13 patients (76.5%) restored sinus rhythm.
Predictors of late AF recurrence
In the Cox univariate regression analysis, significant predictors of late AF recurrence were persistent AF duration, preoperative New York Heart Association functional class, preoperative LA diameter, preoperative RA area, tricuspid valve disease, and preoperative beta-blocker use (Table 2). In the multivariable analysis, persistent AF duration, preoperative LA diameter, preoperative RA area and preoperative beta-blocker use remained statistically significant for AF recurrence (Table 3). According to the ROC curve analysis, the best cutoff value for persistent AF duration, preoperative LA diameter and preoperative RA area were 59.5 months (sensitivity 79.9%, specificity 73.3% and accuracy 74.9%), 59.85 mm (sensitivity 55.8%, specificity 80.8% and accuracy 75.2%) and 25.65 cm2 (sensitivity 75.0%, specificity 65.5% and accuracy 67.4%) respectively (Table 4). Kaplan-Meier survival estimates also verified that patients with persistent AF duration ≥59.5 months, preoperative LA diameter ≥59.85 mm, preoperative RA area ≥25.65 cm2, and preoperative beta-blocker use had significant predictive value of AF recurrence (Figures 1-4).
Table 2. Predictors of AF recurrence in Cox univariate survival regression analysis.
Variables | β | SEM | HR | 95% CI | P value |
---|---|---|---|---|---|
Age (in year) | 0.020 | 0.016 | 0.228 | 0.988–1.053 | 0.228 |
Female gender | 0.167 | 0.301 | 1.181 | 0.654–2.133 | 0.580 |
Persistent AF duration (month) | 0.017 | 0.002 | 1.018 | 1.013–1.023 | <0.001 |
History of embolism | −0.043 | 0.527 | 0.957 | 0.341–2.690 | 0.934 |
Preoperative NYHA Fc class | 0.507 | 0.261 | 1.660 | 0.995–2.768 | 0.049 |
Preoperative LA diameter (mm) | 0.068 | 0.015 | 1.070 | 1.040–1.101 | <0.001 |
Preoperative RA area (cm2) | 0.042 | 0.013 | 1.043 | 1.017–1.070 | 0.001 |
Preoperative EF | 0.006 | 0.012 | 1.006 | 0.982–1.031 | 0.641 |
TVD | 1.206 | 0.420 | 3.341 | 1.466–7.612 | 0.004 |
Preoperative beta-blocker | 0.716 | 0.338 | 2.046 | 1.056–3.966 | 0.034 |
Preoperative calcium blocker | 0.334 | 0.393 | 1.410 | 0.653–3.046 | 0.382 |
Preoperative digoxin | −0.448 | 0.417 | 0.639 | 0.282–1.446 | 0.283 |
Preoperative ACEI | −0.178 | 0.300 | 0.837 | 0.465–1.505 | 0.551 |
ACEI, angiotensin converting enzyme inhibitor; AF, atrial fibrillation; β, regression coefficient; CI, confidence interval; EF, ejection fraction; Fc, functional; HR, hazard ratio; LA, left atrial; NYHA Fc class, New York Heart Association Functional Classification; RA, right atrial; SEM, standard error of the mean; TVD, tricuspid valve disease.
Table 3. Predictors of AF recurrence in Cox multivariate survival regression analysis.
Variables | β | SEM | HR | 95% CI | P value |
---|---|---|---|---|---|
Persistent AF duration (month) | 0.014 | 0.003 | 1.014 | 1.008–1.020 | <0.001 |
Preoperative LA diameter (mm) | 0.071 | 0.019 | 1.073 | 1.033–1.115 | <0.001 |
Preoperative RA area (cm2) | 0.036 | 0.015 | 1.037 | 1.006–1.068 | 0.020 |
Preoperative beta-blocker | 1.173 | 0.413 | 3.231 | 1.438–7.259 | 0.005 |
AF, atrial fibrillation; β, regression coefficient; LA, left atrial; RA, right atrial; SEM, standard error of the mean; HR, hazard ratio; CI, confidence interval.
Table 4. Predictive values for AF recurrence by receiver-operating characteristic curve.
Variables | Best cut-off value | AUC (95% CI) | Sensitivity (%) | Specificity (%) | Accuracy (%) |
---|---|---|---|---|---|
Persistent AF duration (month) | 59.50 | 0.799 (0.717–0.882) | 79.9 | 73.3 | 74.9 |
Preoperative LA diameter (mm) | 59.85 | 0.732 (0.643–0.822) | 55.8 | 80.8 | 75.2 |
Preoperative RA area (cm2) | 25.65 | 0.709 (0.616–0.802) | 75.0 | 65.5 | 67.4 |
Best cut-off value is equal to the biggest Youden index, Youden index, sensitivity + specificity − 1; AF, atrial fibrillation; AUC, area under the curve; CI, confidence interval; LA, left atrial; RA, right atrial.
Discussion
Catheter ablation versus surgical ablation
Currently, catheter ablation of paroxysmal or persistent AF is a common practice although the primary success rate even including the recent state-of-art technology of cryoballoon could only achieve 60% at 12 months and this could be improved to 76.9% after repetitive procedures (16). In contrast, we demonstrated the primary success rate of 74.4% in a cohort of mitral disease with persistent AF during follow-up period of 101±50.9 months by RF maze procedure with concomitant mitral surgery. Similarly, in a case-matched comparison of catheter-based techniques and Cox-Maze III operation conducted by Stulak et al., the superiority of surgical ablation including better free of AF, less antiarrhythmics and anticoagulation use were reported (17). Several catheter ablation related adverse events like pulmonary vein stenosis, esophageal injury, and cardiac perforation related tamponade were all well-known complications. In between, pulmonary vein stenosis is a serious issue which may require later catheter intervention or even pulmonary resection procedures. In addition, 3% of vascular access complication was not negligible (17). These complications were seldom reported in the surgical ablation groups.
Modified monopolar RF saline irrigated AF ablation
Various energy sources including RF, microwave, high-intensity focused ultrasound, and cryothermia have been introduced to replace the conventional cut-and-saw maze procedure (18-20). These modifications made the AF ablation safer and easier resulted in versatile concomitant application of surgical AF ablation in various cardiac procedures, especially in mitral surgery. In this study, RF ablation was performed using a monopolar RF ablator delivering a continuous, quasi-sinusoidal, unmodulated RF output at 500 kHz. During the point-to-point ablation, saline irrigation was used continuously and transmural discoloration of each lesion was confirmed to ascertain the adequate continuity and depth of the ablation line. As an adjunction, cryoablative lesions were also made at some particular anatomical sites (12). By this monopolar saline irrigated RF maze procedure, we achieved the results of 2.9% of the 30-day mortality, 3.9% of the in-hospital mortality, 1.4% of stroke rate, and 3.9% of permanent pacer implantation rate. These results are comparable to that of the current state-of-art results reported as 4.4% of 30-day mortality, 5.5% of stroke rate, and 7.0% of permanent pacer implantation rate (21).
Heterogeneity of modified RF AF ablation
The incidence of AF increased in the patients indicated for cardiac surgery and AF was also reported to be a significant risk factor of surgical mortality (22-23). Therefore, concomitant AF ablation was inferred and justified for reducing the mortality and improving the quality of life. However, it is noteworthy that concomitant AF ablation in different cardiac surgeries demonstrated heterogeneous outcomes. According the report from Budera et al., mitral surgery showed superior benefit than coronary and aortic valve surgeries (24).
Another issue regarding the heterogeneity of RF ablation is the adoption of different device, technique, and lesion set which inevitably resulted in varied outcomes. The transmurality and continuity of lesions are important but tricky terms without objective consensus. The “ablation factors” including delivered energy, ablation duration, lesion set, lesion depth, lesion width, and even saline irrigation amount are all varied between operators. Consequently, the results of RF maze procedure varied between surgeons. In our practice, we standardize the procedure by creating the point to point continuous RF lesions with precise protocol regarding the “ablation factors” to achieve the consistent ablation result as possible (12-14). Certainly, a method for real-time confirmation of complete conduction block between the RF lesions in a beating heart is the most demanding facility for refinement of the RF maze procedure.
Post-ablative permanent pacemaker implantation
Gillinov et al. reported a greater incidence of pacemaker implantation in ablation group mostly for the heart block and sinus node dysfunction compared to mitral surgery alone group (25). Aggressive implantation strategies have been advocated for atypical bradydysrhythmias in rheumatic population after AF ablation (26,27). In contrast, high degree atrioventricular block or bundle branch block was considered as the indication in different studies (28,29). In our study, high degree atrioventricular block was seldom occurred and the permanent pacemaker implantation rate was low for the sinoatrial node sparing lesion set was adopted in our practice (13).
Thromboembolism after AF ablation
In the surgical group, obliteration of LA appendage and LA thrombectomy could be performed effectively. In addition, surgical ablation also achieved superior long-term sinus restoration. These surgical advantages might reflect on the observations made by Boersma et al. that lower incidence of stroke and thrombus formation were noted in the surgical ablation group than catheter ablation group at 12-month follow-up (30). In our practice, after routine 6-week of anticoagulation therapy, warfarin was discontinued if sinus rhythm had been restored in patients after successful valvular repair or bioprosthetic replacement. During the mean follow-up period of 101±50.9 months, stroke was documented in only 3 patients (1.4%; 2 in failure group).
Predictors
In our previous study, we demonstrated that sinus conversion rate was significantly lower in the patients with preoperative LA diameter >56.8 mm and AF duration >66 months (31). In present investigation, in addition to the preoperative LA diameter (>59.85 mm) and the persistent AF duration (>59.5 months), a larger preoperative RA area (>25.65 cm2) and preoperative beta-blocker use were identified as the negative predictors for the successful sinus conversion. Theoretically, with increasing RA area, the electrical substrate of RA tissue might become more vulnerable to propagate AF recurrence. This additional finding in our study will be important to predict the patient with AF recurrence after sole left side maze operation. Preoperative beta-blocker use is another novel predictor of late AF recurrence detected in this study. Beta-blockers act by blocking the beta 1-adrenergic receptor, thereby reducing sympathetic activity for AF control. Consequently, preoperative beta-blocker use might suggest that the patients were under higher sympathetic status that might vulnerable to postoperative late AF recurrence.
Limitations of the study
The nature of retrospective, non-randomized, and heterogeneity of this study constitutes the inevitable weakness. Although, this cohort might demonstrate one of the longest follow-up studies in a significant number of patients, a larger prospective randomized study is mandatory for determining the best lesion set and predicting the precise risk factors of AF recurrence. Although we demonstrated that the longer persistent AF duration, larger preoperative LA diameter, larger preoperative RA area and preoperative beta-blocker use were the predictors for negative long-term outcome of RF maze procedure for the patients with persistent AF, we cannot propose the solution to improve the sinus conversion rate in patients with those negative predictors. Lack of modality to document the continuous heart rhythm is the universal weakness in dysrhythmia study. Rapid refinement of portable electronic device for continuous monitoring of heart rhythm will circumvent this predicament in the near future.
Conclusions
In conclusion, monopolar saline irrigated RF maze procedure with concomitant mitral valve surgery demonstrated acceptable sinus conversion rate with low incidences of postoperative stroke and permanent pacemaker implantation in a long-term follow-up. Longer persistent AF duration, larger preoperative LA diameter, larger preoperative RA area and preoperative beta-blocker use were the predictors for negative long-term outcome. Timely referral of patients for surgery is mandatory.
Acknowledgements
None.
Ethical Statement: This study was approved by the Institutional Review Board of Chang Gung Medical Foundation (IRB number 201600911B0), and the need for written informed consent from the patients was waived.
Footnotes
Conflicts of Interest: The authors have no conflicts of interest to declare.
References
- 1.Ostrander LD, Jr, Brandt RL, Kjeldsberg MO, et al. Electrocardiographic findings among the adult population of a total natural community, Tecumseh, Michigan. Circulation 1965;31:888-98. 10.1161/01.CIR.31.6.888 [DOI] [PubMed] [Google Scholar]
- 2.Chesebro JH, Fuster V, Halperin JL. Atrial fibrillation: risk marker for stroke. N Engl J Med 1990;323:1556-8. 10.1056/NEJM199011293232209 [DOI] [PubMed] [Google Scholar]
- 3.Benjamin EJ, Wolf PA, D’Agostino RB, et al. Impact of atrial fibrillation on the risk of death: the Framingham heart study. Circulation 1998;98:946-52. 10.1161/01.CIR.98.10.946 [DOI] [PubMed] [Google Scholar]
- 4.Chen JW, Lin CH, Hsu RB. Mechanisms of early and delayed stroke after systematic off-pump coronary artery bypass. J Formos Med Assoc 2015;114:988-94. 10.1016/j.jfma.2014.01.010 [DOI] [PubMed] [Google Scholar]
- 5.Sun MC, Hsiao PJ. In-hospital case management to increase anticoagulation therapy for stroke patients with atrial fibrillation: A hospital-based registry. J Formos Med Assoc 2013;112:263-8. 10.1016/j.jfma.2012.02.016 [DOI] [PubMed] [Google Scholar]
- 6.Grigioni F, Avierinos JF, Ling LH, et al. Atrial fibrillation complicating the course of degenerative mitral regurgitation: determinants and long-term outcome. J Am Coll Cardiol 2002;40:84-92. 10.1016/S0735-1097(02)01922-8 [DOI] [PubMed] [Google Scholar]
- 7.Cox JL, Schuessler RB, D’Agostino HJ, Jr, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg 1991;101:569-83. [PubMed] [Google Scholar]
- 8.Cox JL, Jaquiss RD, Schuessler RB, et al. Modification of the maze procedure for atrial flutter and atrial fibrillation. II. Surgical technique of the maze III procedure. J Thorac Cardiovasc Surg 1995;110:485-95. 10.1016/S0022-5223(95)70245-8 [DOI] [PubMed] [Google Scholar]
- 9.Lee JW, Choo SJ, Kim KI, et al. Atrial fibrillation surgery simplified with cryoablation to improve left atrial function. Ann Thorac Surg 2001;72:1479-83. 10.1016/S0003-4975(01)03176-9 [DOI] [PubMed] [Google Scholar]
- 10.Sie HT, Beukema WP, Ramdat Misier AR, et al. Radiofrequency modified maze in patients with atrial fibrillation undergoing concomitant cardiac surgery. J Thorac Cardiovasc Surg 2001;122:249-56. 10.1067/mtc.2001.114633 [DOI] [PubMed] [Google Scholar]
- 11.Kamata J, Kawazoe K, Izumoto H, et al. Predictors of sinus rhythm restoration after Cox maze procedure concomitant with other cardiac operations. Ann Thorac Surg 1997;64:394-8. 10.1016/S0003-4975(97)00139-2 [DOI] [PubMed] [Google Scholar]
- 12.Chen MC, Guo BF, Chang JP, et al. Radiofrequency and cryoablation of atrial fibrillation in patients undergoing valvular operations. Ann Thorac Surg 1998;65:1666-72. 10.1016/S0003-4975(98)00230-6 [DOI] [PubMed] [Google Scholar]
- 13.Chen MC, Chang JP, Chen CJ, et al. Atrial pacemaker complex preserved radiofrequency maze procedure reducing the incidence of sick sinus syndrome in patients with atrial fibrillation. Chest 2005;128:2571-5. 10.1378/chest.128.4.2571 [DOI] [PubMed] [Google Scholar]
- 14.Chang JP, Chen MC, Kao CL, et al. Role of the simultaneous sequential strategy for failed acute sinus restoration after modified left maze procedure for persistent atrial fibrillation with concomitant mitral surgery. World J Surg 2006;30:1802-8. 10.1007/s00268-006-0382-0 [DOI] [PubMed] [Google Scholar]
- 15.Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification: a report from the American Society of Echocardiography’s Guidelines and Standards Committee and the Chamber Quantification Writing Group, developed in conjunction with the European Association of Echocardiography, a branch of the European Society of Cardiology. J Am Soc Echocardiogr 2005;18:1440-63. 10.1016/j.echo.2005.10.005 [DOI] [PubMed] [Google Scholar]
- 16.Vogt J, Heintze J, Gutleben KJ, et al. Long-term outcomes after cryoballoon pulmonary vein isolation: results from a prospective study in 605 patients. J Am Coll Cardiol 2013;61:1707-12. 10.1016/j.jacc.2012.09.033 [DOI] [PubMed] [Google Scholar]
- 17.Stulak JM, Dearani JA, Sundt TM 3rd, et al. Ablation of atrial fibrillation: comparison of catheter-based techniques and the Cox-Maze III operation. Ann Thorac Surg 2011;91:1882-8; discussion 1888-9. [DOI] [PubMed]
- 18.Ad N, Henry L, Massimiano P, et al. The state of surgical ablation for atrial fibrillation in patients with mitral valve disease. Curr Opin Cardiol 2013;28:170-80. 10.1097/HCO.0b013e32835ced9c [DOI] [PubMed] [Google Scholar]
- 19.MacDonald DR, Maruthappu M, Nagendran M. How effective is microwave ablation for atrial fibrillation during concomitant cardiac surgery? Interact Cardiovasc Thorac Surg 2012;15:122-7. 10.1093/icvts/ivs137 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20.Williams MR, Garrido M, Oz MC, et al. Alternative energy sources for surgical atrial ablation. J Card Surg 2004;19:201-6. 10.1111/j.0886-0440.2004.04037.x [DOI] [PubMed] [Google Scholar]
- 21.Phan K, Xie A, Tian DH, et al. Systemic review and meta-analysis of surgical ablation for atrial fibrillation during mitral valve surgery. Ann Cardiothorac Surg 2014;3:3-14. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Crandall MA, Horne BD, Day JD, et al. Atrial fibrillation significantly increases total mortality and stroke risk beyond that conveyed by the CHADS2 risk factors. Pacing Clin Electrophysiol 2009;32:981-6. 10.1111/j.1540-8159.2009.02427.x [DOI] [PubMed] [Google Scholar]
- 23.Saxena A, Dinh D, Dimitriou J, et al. Preoperative atrial fibrillation is an independent risk factor for mid-term mortality after concomitant aortic valve replacement and coronary artery bypass graft surgery. Interact Cardiovasc Thorac Surg 2013;16:488-94. 10.1093/icvts/ivs538 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 24.Budera P, Straka Z, Osmančík P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicenter study. Eur Heart J 2012;33:2644-52. 10.1093/eurheartj/ehs290 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 25.Gillinov AM, Gelijns AC, Parides MK, et al. Surgical ablation of atrial fibrillation during mitral valve surgery. N Engl J Med 2015;372:1399-409. 10.1056/NEJMoa1500528 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26.Vasconcelos JT, Scanavacca MI, Sampaio RO, et al. Surgical treatment of atrial fibrillation through isolation of the left atrial posterior wall in patients with chronic rheumatic mitral valve disease. A randomized study with control group. Arq Bras Cardiol 2004;83:211-8. [DOI] [PubMed] [Google Scholar]
- 27.Abreu Filho CA, Lisboa LA, Dallan LA, et al. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation 2005;112: I20-5. [DOI] [PubMed] [Google Scholar]
- 28.Akpinar B, Guden M, Sgbas E, et al. Combined radiofrequency modified maze and mitral valve procedure through a port access approach: early and mid-term results. Eur J Cardiothorac Surg 2003;24:223-30. 10.1016/S1010-7940(03)00258-6 [DOI] [PubMed] [Google Scholar]
- 29.Blomström-Lundqvist C, Johansson B, Berglin E, et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish Multicentre Atrial Fibrillation study (SWEDMAF). Eur Heart J 2007;28:2902-8. 10.1093/eurheartj/ehm378 [DOI] [PubMed] [Google Scholar]
- 30.Boersma LV, Castella M, van Boven W, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation 2012;125:23-30. 10.1161/CIRCULATIONAHA.111.074047 [DOI] [PubMed] [Google Scholar]
- 31.Chen MC, Chang JP, Chang HW, et al. Clinical determinants of sinus conversion by radiofrequency maze procedure for persistent atrial fibrillation in patients undergoing concomitant mitral valvular surgery. Am J Cardiol 2005;96:1553-7. 10.1016/j.amjcard.2005.07.063 [DOI] [PubMed] [Google Scholar]